LEONI, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 14.188
EU - Europa 7.995
AS - Asia 6.417
SA - Sud America 1.715
AF - Africa 418
Continente sconosciuto - Info sul continente non disponibili 388
OC - Oceania 10
Totale 31.131
Nazione #
US - Stati Uniti d'America 13.924
SG - Singapore 1.955
UA - Ucraina 1.410
BR - Brasile 1.357
VN - Vietnam 1.352
RU - Federazione Russa 1.290
IT - Italia 1.033
CN - Cina 934
SE - Svezia 861
DE - Germania 769
IE - Irlanda 711
TR - Turchia 677
DK - Danimarca 542
HK - Hong Kong 520
FR - Francia 450
FI - Finlandia 409
KR - Corea 297
GB - Regno Unito 279
IN - India 163
CI - Costa d'Avorio 155
MA - Marocco 127
CA - Canada 122
AR - Argentina 108
BD - Bangladesh 102
MX - Messico 83
IQ - Iraq 61
ZA - Sudafrica 61
CO - Colombia 60
EC - Ecuador 58
ID - Indonesia 55
JP - Giappone 45
PL - Polonia 44
VE - Venezuela 44
UZ - Uzbekistan 36
PK - Pakistan 35
NL - Olanda 33
BE - Belgio 30
ES - Italia 30
PH - Filippine 30
PY - Paraguay 29
EU - Europa 25
AT - Austria 24
CL - Cile 22
JO - Giordania 22
DZ - Algeria 19
MY - Malesia 19
PE - Perù 16
TN - Tunisia 15
CZ - Repubblica Ceca 12
JM - Giamaica 12
AE - Emirati Arabi Uniti 11
KZ - Kazakistan 11
NP - Nepal 11
RO - Romania 11
BO - Bolivia 10
CR - Costa Rica 10
ET - Etiopia 10
KE - Kenya 10
UY - Uruguay 10
AZ - Azerbaigian 9
HU - Ungheria 9
LT - Lituania 9
OM - Oman 9
AU - Australia 8
BG - Bulgaria 8
SA - Arabia Saudita 8
LB - Libano 7
PR - Porto Rico 7
TH - Thailandia 7
EG - Egitto 6
GT - Guatemala 6
TW - Taiwan 6
IL - Israele 5
IR - Iran 5
AL - Albania 4
CG - Congo 4
CH - Svizzera 4
EE - Estonia 4
GR - Grecia 4
HN - Honduras 4
KG - Kirghizistan 4
NI - Nicaragua 4
BA - Bosnia-Erzegovina 3
BZ - Belize 3
DO - Repubblica Dominicana 3
HR - Croazia 3
KW - Kuwait 3
PT - Portogallo 3
SN - Senegal 3
SV - El Salvador 3
BB - Barbados 2
BH - Bahrain 2
GE - Georgia 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
MQ - Martinica 2
PA - Panama 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
Totale 30.746
Città #
Ashburn 1.612
Jacksonville 1.427
Singapore 1.097
Chandler 1.049
Fairfield 780
Dallas 711
Dublin 707
Boardman 704
Council Bluffs 629
San Jose 609
Hong Kong 500
Wilmington 479
Ho Chi Minh City 438
New York 377
Woodbridge 351
Houston 313
Seattle 295
San Mateo 291
Hanoi 286
Lawrence 286
Princeton 286
Lauterbourg 252
The Dalles 245
Des Moines 233
Moscow 221
Beijing 212
Cambridge 212
Los Angeles 212
Ann Arbor 189
Hefei 171
Centro 166
Abidjan 155
Milan 136
San Diego 116
São Paulo 113
Buffalo 105
Munich 93
Redmond 93
Helsinki 89
Da Nang 83
Porto 79
Orem 74
Haiphong 54
Turin 53
Santa Clara 52
Phoenix 48
Shanghai 46
London 45
Chicago 41
Miano 39
Tokyo 37
Rio de Janeiro 35
Curitiba 34
Guangzhou 34
Montreal 34
Pune 34
Turku 34
Chennai 33
Warsaw 33
Stockholm 31
Brooklyn 29
Tashkent 29
Hải Dương 28
Brussels 27
Norwalk 27
Pianella 27
Johannesburg 26
Atlanta 25
Denver 25
Mumbai 25
Toronto 25
Belo Horizonte 24
Biên Hòa 24
Manchester 24
Mexico City 24
Rome 24
Boston 23
Marche 23
Porto Alegre 23
Amman 21
Baghdad 21
Frankfurt am Main 21
Nuremberg 21
Poplar 21
Izmir 20
Medellín 19
San Francisco 19
Amsterdam 18
Ancona 18
Guayaquil 18
Thái Nguyên 17
Auburn Hills 16
Brasília 16
Civitanova Marche 15
Columbus 15
Elk Grove Village 15
Washington 15
Wuhan 15
Campinas 14
Caracas 14
Totale 18.044
Nome #
Human white adipocytes convert into “rainbow” adipocytes in vitro 271
Human de-differentiated adipocytes show similar properties to bone marrow derived mesenchymal stem cells 221
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 212
Differences in survivin localization and Bcl-2 expression in CD30+ lymphoproliferative disorderd of the skin compared to systemic anaplastic large cell lymphomas: an immunohistochemical study 202
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 189
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 184
Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme 181
Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. 179
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 178
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 175
Glial-like differentiation potential of human mature adipocytes 172
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 169
Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes 168
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 166
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 164
Primary B-cell lymphoblastic lymphoma of the testis 163
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 162
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 162
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 161
Human bone marrow adipocytes maintain the survival and differentiation of hematopoietic stem cells 156
[Hodgkin's lymphoma and secondary leukemias]. 155
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]. 154
Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: The role of the WHO histological diagnosis 154
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 154
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 154
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 153
Meningioma-like cerebral relapse of Hodgkin's disease. 152
Bone marrow adipocytes support haematopoietic stem cell survival 152
[Autoimmune thrombocytopenic purpura and circulating immune complexes]. 151
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 151
Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas 150
Ematuria ed emospermia ricorrenti: uniche manifestazioni di malattia di von Willebrand di tipo I. First report 150
Biosafety evidence for human dedifferentiated adipocytes 149
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 148
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 147
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 147
Coexistence of two discordant B-cell lymphomas in the skin and lymph node: report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma. 146
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 146
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 145
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 144
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line]. 144
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 144
[Polyneuropathies associated with lymphoplasmacytic dyscrasias: the clinical and instrumental characteristics of a 38-patient case load]. 144
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 143
Human Mesenchymal Stem Cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion 143
Spontaneous recurrent hematuria and hematospermia: Unique manifestations of von Willebrand disease type I. Case report 142
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 142
Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides. 142
Plasticity of human dedifferentiated adipocytes toward endothelial cells 140
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate 140
Primary testicular lymphoblastic B lymphoma: ultrasonographic features and clinical implications 140
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 140
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 139
A circulating T cell clone in early Mycosis Fungoides is not a negative prognostic factor when the disease is treated by a combination of PUVA plus interferon alpha 138
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 136
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 136
Immunostaining for nucleophosmin in bone marrow trephine biopsy specimens in acute myeloid leukemias 135
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase 3 study 134
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 134
A case of monoclonal gammopathy of undetermined significance (MGUS): type IgD-lambda. 134
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 134
[Polychemotherapy versus melphalan-prednisone in multiple myeloma]. 133
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 133
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 133
Screening of psychological distress in oncology and hematology department at Ospedali Riuniti Ancona 133
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation 132
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 132
Diffuse large B-cell lymphoma with Homer-Wright rosettes, sinusoidal growth pattern, and CD30 expression: a possible overlapping between micovillous lymphomas and sinusal CD30-positive large B-cell lymphomas. 131
Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C 130
[Beta 2-microglobulin in lymphoproliferative disorders]. 129
Bone marrow extracellular large geometric crystals in IgG/λ MGUS 128
Central nervous system involvement is a negative prognostic factor in primary cutaneous B-cell lymphoma. 128
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 127
Molecular and functional characterization of human bone marrow adipocytes 127
Severe diarrhoea During Campath-1H Treatment For Refractory Cutaneous T Cell Lymphoma 127
[Peripheral neuropathy associated with Castleman's lymphoma]. 126
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 126
[Hairy cell leukemia: therapy with lithium carbonate]. 126
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 125
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 124
Efficacy and safety of eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: interim analysis of a prospective, randomized, single-blind, placebo-controlled trial (EQoL-MDS) 124
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 124
Identification of different adypocytes populations within human marrow microenvironment 124
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 124
Prognostic clinical, laboratoristic and molecular factors in mycosis fungoides 123
CD8+ lymphocytes and CD1a+ dendritic cells in mycosis fungoides: correlation with epidermotropism, subepidermal lymphoid infiltrate, response to therapy and disease recurrence 122
Bone Marrow histopathological and molecular changes of small B-cell lymphomas after rituximab therapy: comparison with clinical response and patients autcome 122
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 121
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes 121
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. 120
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. 120
The risk of non-Hodgkin's lymphoma in coeliac disease: a case-control, multicentre study 119
Thalidomide plus oral melphalan for advanced multiple myeloma: a phase Ii study 119
Early stage Mycosis Fungoides treated with IFNalpha2b and PUVA: molecular analysis of T cell monoclonality by PCR in skin biopsies during and after therapy. 119
Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. 119
Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. 119
Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow 118
Unusual Site Thrombosis: Focus on Myeloproliferative Neoplasms with Splachnic or Cerebral Venous Thrombosis 118
AMIFOSTINE CAN REDUCE MUCOSAL DAMAGE AFTER HIGH-DOSE MELPHALANCONDITIONING FOR PERIPHERAL BLOOD PROGENITOR CELL AUTOTRANSPLANT: A RETROSPECTIVE STUDY. EFFECT OF AMIFOSTINE ON MUCOSITIS DURING AUTOLOGOUS PBPC TRANSPLANTATION 117
Prospective multicentric Clinical trial on the use of Interferon-a plus PUVA in patients with early stage Mycosis Fungoides. 116
Totale 14.420
Categoria #
all - tutte 143.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.468 0 0 23 176 16 79 99 171 115 178 158 453
2022/20233.296 343 373 278 258 254 492 1 172 864 19 178 64
2023/20241.955 350 49 102 341 334 369 27 46 5 38 20 274
2024/20253.923 429 424 172 48 169 78 486 113 868 285 353 498
2025/202610.101 707 793 707 1.237 898 726 1.713 1.040 785 765 222 508
2026/20271.249 382 473 394 0 0 0 0 0 0 0 0 0
Totale 31.131